About us
Products
Careers
Investor Relations
News
Cares
Language:
- Italiano
- English

Home » News » NEW INTERNATIONAL AGREEMENTS FOR THE CETILAR® LINE

NEW INTERNATIONAL AGREEMENTS FOR THE CETILAR® LINE

Published: 06 May 2019 08:41

<< Articolo precedente Next Article >>

Related News

IQVIA-FederSalus: SiderAL® Forte is the market’s...

The food supplement market is growing in Italy and SiderAL® Forte 20 capsules is the most sold nutritional...
PharmaNutra obtains patent for a new composition...

The new patent, valid until 2037, opens PharmaNutra up to the possibility of developing specific products...

Related Products

DiKappa2

Dikappa2 is a nutritional supplement containing Vitamin K2 and Vitamin D which promotes intestinal calcium...
UltraMag

UltraMag^® is a food supplement with magnesium, that is useful to cover dietary deficiencies...

Pharmanutra SpA is a pharmaceutical company based in Pisa. It was founded in 2003 with the aim of developing nutraceuticals and medical devices. Pharmanutra follows rigorous standards of quality by maintaining a high attention to the raw materials used, unique and exclusive for the whole national territory.

PharmaNutra Spa | Registered office

Via Delle Lenze, 216/b

56122 Pisa

Tel. +39 050 7846500

Fax +39 050 7846524

C.F. / P.Iva / Reg. Impr. 01679440501

Codice Destinatario Fatturazione Elettronica SUBM70N

Cap.Soc. € 1.123.097,70

I.V. | REA 146259

Privacy policy
Cookie policy
General conditions
Code of ethics
Mod. 231

NEWSLETTER

Subscribe to the Pharmanutra newsletter and you will be constantly updated on all our activities.

Read Newsletter Disclosure

AWARDS

QUALITY

© Copyright - PHARMANUTRA.IT

All Rights Reserved.

This site is set to allow the use of all cookies in order to ensure a better navigation. If you continue to browse, you accept our cookies use. Read More